Detail akcie Teleflex online

Business Summary: Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Teleflex Inc revenues increased 17% to $1.99B. Net income before extraordinary items increased 2% to $58.5M. Revenues reflect EMEA segment increase of 39% to $472.4M, Americas segment increase of 11% to $1.28B, Asia segment increase of 19% to $241.1M, Europe segment increase of 39% to $484.7M, United States segment increase of 9% to $1.18B, Asia Pacific segment increase of 21% to $218M.